LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged acacia · clear

Patent Litigation

Record 20.4% move in 3Q for Public IP company stock index (PIPX)

Public IP licensing companies (PIPCOs) are very much alive and some company shares are doing surprisingly well, despite increased obstacles to patent licensing. PIPX reported a 20.4% gain for the 3Q vs. just 3.3% for the S&P 500 . It was the PIPX’s…

October 21, 2016·Patent Litigation·2 min read
Patent Litigation

Corporate love for litigation

NPEs historically get a pretty raw deal when it comes to PR, with article after article amounting against the practice of essentially turning patents into commodities. The tides have slowly been turning for companies like Intellectual Ventures (IV) and…

August 19, 2012·Patent Litigation·4 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.